BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/27/2022 4:55:05 AM | Browse: 224 | Download: 526
Publication Name World Journal of Clinical Cases
Manuscript ID 78693
Country/Territory China
Received
2022-07-21 11:00
Peer-Review Started
2022-07-21 11:02
To Make the First Decision
Return for Revision
2022-08-04 07:41
Revised
2022-08-16 15:38
Second Decision
2022-09-20 03:25
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2022-09-21 00:29
Articles in Press
2022-09-21 00:29
Publication Fee Transferred
Edit the Manuscript by Language Editor
2022-09-18 09:54
Typeset the Manuscript
2022-10-17 13:42
Publish the Manuscript Online
2022-10-27 04:55
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Infectious Diseases
Manuscript Type Observational Study
Article Title Efficacy and safety profile of two-dose SARS-CoV-2 vaccines in cancer patients: An observational study in China
Manuscript Source Unsolicited Manuscript
All Author List Sheng-Wei Cai, Jin-Yan Chen, Rong Wan, De-Jian Pan, Wei-Lin Yang and Ren-Gui Zhou
ORCID
Author(s) ORCID Number
Rong Wan http://orcid.org/0000-0002-5575-7292
Wei-Lin Yang http://orcid.org/0000-0002-9564-6132
Funding Agency and Grant Number
Corresponding Author Rong Wan, BHMS, Chief Nurse, Department of Quality Control, The 904th Hospital of Joint Logistic Support Force, No. 101 Xingyuan North Road, Wuxi 214044, Jiangsu Province, China. yings2007@21cn.com
Key Words SARS-CoV-2; Vaccine; Cancer; COVID-19; Immunotherapy
Core Tip Newer strains of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have made the ongoing global coronavirus disease 2019 pandemic critical. Patients with cancer form a high-risk group, as those with active cancer or those treated with immunosuppressive therapies are more likely to be infected by SARS-CoV-2. Our study indicated the efficacy and safety of two-dose SARS-CoV-2 vaccines in cancer subjects.
Publish Date 2022-10-27 04:55
Citation Cai SW, Chen JY, Wan R, Pan DJ, Yang WL, Zhou RG. Efficacy and safety profile of two-dose SARS-CoV-2 vaccines in cancer patients: An observational study in China. World J Clin Cases 2022; 10(31): 11411-11418
URL https://www.wjgnet.com/2307-8960/full/v10/i31/11411.htm
DOI https://dx.doi.org/10.12998/wjcc.v10.i31.11411
Full Article (PDF) WJCC-10-11411.pdf
Full Article (Word) WJCC-10-11411.docx
Manuscript File 78693_Auto_Edited-JJW-WangTQ-JLW.docx
Answering Reviewers 78693-Answering reviewers.pdf
Audio Core Tip 78693-Audio core tip.mp3
Biostatistics Review Certificate 78693-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form 78693-Conflict-of-interest statement.pdf
Copyright License Agreement 78693-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s) 78693-Informed consent statement.pdf
Institutional Review Board Approval Form or Document 78693-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate 78693-Language certificate.pdf
Peer-review Report 78693-Peer-review(s).pdf
Scientific Misconduct Check 78693-Bing-Wang JJ-2.png
Scientific Editor Work List 78693-Scientific editor work list.pdf